Tempus AI (TEM) surged 8.06% in pre-market trading following the release of its preliminary fourth-quarter and full-year 2025 results. The company reported Q4 revenue of approximately $367 million, marking an 83% year-over-year increase, driven by strong growth in diagnostics and data applications revenue.
Additionally, Tempus announced a record Total Contract Value (TCV) exceeding $1.1 billion, reflecting heightened demand for its AI-driven precision medicine solutions. The company's CEO highlighted accelerating growth in both diagnostics and data licensing businesses, positioning Tempus for a strong 2026.